ATAI earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E -2.39. Updated 2026-07-23.
Atai Beckley (ATAI) Research Hub
Atai Beckley (ATAI) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-10, shares last closed at 7.35 USD (+0.82%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.39, market cap 2.63B. This hub links to the full technical, earnings and options research available for ATAI.
Last updated 2026-09-10 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 7.35 USD (+0.82%) |
| 52-week range | 3.83 USD – 7.45 USD |
| Trend regime | Range |
| 14-day RSI | 56.9 (Bullish) |
| Trailing P/E | -2.39 |
| Market cap | 2.63B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for ATAI
Covered Call on ATAI: how it works, illustrative setup around the real 7.35 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ATAI: how it works, illustrative setup around the real 7.35 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ATAI: how it works, illustrative setup around the real 7.35 USD price, max profit/loss, breakeven and when to use it. Educational.
ATAI technical analysis: range, last 7.35 USD, RSI 56.9, 52w range 3.83 USD–7.45 USD, real support/resistance. Updated 2026-09-10.
More on SniperIQ
Frequently asked questions
What sector is ATAI in?
Atai Beckley (ATAI) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ATAI in an uptrend or downtrend?
As of 2026-09-10, ATAI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ATAI's trailing P/E ratio?
ATAI's trailing P/E is -2.39, with a market cap of 2.63B. See the earnings research page for full valuation detail.
When does ATAI next report earnings?
ATAI is next scheduled to report earnings on 2026-08-13.